Developer docs
API playgroundTry for free, no card

Search company profiles

MedSleuth

Full company profile

uuid0007fp6

Namestring
MedSleuth
Legal namestring
MedSleuth, Inc.
Websiteurl
medsleuth.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

MedSleuth is a San Francisco-based healthcare technology company that develops the BREEZE™ platform, a clinically-validated, cloud-based web application that collects medical histories directly from patients using proprietary clinical algorithms and a medication-driven recall methodology. The platform is delivered as four integrated modules — BREEZE Transplant (full transplant continuum from referral through donor/recipient follow-up and UNOS/CMS compliance), KidneyMatchgrid (paired kidney donation matching via a partnership with the Alliance for Paired Kidney Donation, powered by a Nobel Prize-winning optimization algorithm), BREEZE Clinical Trials (remote screening, enrollment, adverse event monitoring, and FDA REMS compliance for pharma sponsors and trial sites), and BREEZE Preoperative (standardized perioperative risk assessment for hospitals and surgical centers).

The company serves a focused set of U.S. institutional customers — transplant centers, hospitals, surgical centers, and clinical trial sponsors — through a consultative enterprise sales motion with demo requests and quote-based pricing on annual subscriptions. The platform integrates with customer EHRs, is HIPAA-compliant, holds SOC 2 Type II certification, and has been validated by the U.S. Department of Defense and the National Institutes of Health. Despite operating with a micro team of 1–10 employees, MedSleuth has positioned the BREEZE platform across multiple high-value clinical workflows, with product and partnership expansion activity concentrated in 2025 and an apparent structural linkage to DaVita indicated by privacy notice domains hosted at davita.com.

Short descriptiontext

MedSleuth builds the BREEZE™ cloud platform, which collects patient medical histories and supports U.S. transplant centers, hospitals, surgical centers, and clinical trial sponsors with modules for transplant management, kidney paired donation matching (via APKD), clinical trial enrollment, and preoperative risk assessment.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
healthcare workflow software, transplant management software, preoperative assessment platform, clinical trial patient screening, medical history automation
Industry2 codes
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
NAICS code2 codes
  • Computer Systems Design and Related Services54151
  • Home Health Care Services621610
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Healthcare Workflow Software
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1BREEZE™ Software Licensing
TypeSubscription Recurring
Description

Enterprise software licensing model for BREEZE™ platform deployed to healthcare providers including transplant centers, hospitals, and clinical trial sites. The platform appears to be sold as a subscription-based or per-transaction model targeting institutional healthcare customers.

medsleuth.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Enterprise licensing with custom pricing
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based pricing not publicly disclosed. Contact form for demo scheduling indicates B2B enterprise sales motion with custom pricing based on institutional needs.

medsleuth.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 2 records shown
1BREEZE
Description

A clinically-validated web-based platform for collecting medical histories directly from patients, used for transplant management, preoperative assessments, and clinical trials. Includes modules for recipient referral, candidate evaluation, waitlist management, living donor evaluation, and follow-up.

medsleuth.com
+1 more record
Core offering1 text field

MedSleuth develops and sells the BREEZE™ web-based platform, a clinically-validated software suite that automates medical history collection, patient eligibility screening, and clinical workflow management for transplant centers, hospitals, surgical centers, and clinical trial sponsors. The suite includes specialized modules for transplant management (BREEZE Transplant™), kidney donor-recipient matching (KidneyMatchgrid), preoperative assessment (BREEZE™ Preoperative), and clinical trial patient onboarding (BREEZE™ Clinical Trials).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 97% Ease of Use rating from users
+5 more records
Product overview1 text field

MedSleuth is a unified healthcare technology platform built around its core BREEZE™ software product. The platform consists of multiple integrated modules: BREEZE Transplant™ for managing the full kidney transplant continuum from referral through follow-up; KidneyMatchgrid, a kidney matching tool developed in partnership with APKD that uses a Nobel Prize-winning algorithm for paired donation optimization; BREEZE™ Clinical Trials for patient enrollment and REMS compliance; and BREEZE™ Preoperative for standardized preoperative risk assessment. All modules share the same web-based platform architecture for collecting medical histories directly from patients.

Product and service5 records
1BREEZE™ Clinical Platform
CategoryClinical Workflow Software
2BREEZE Transplant™
CategoryTransplant Management Software
3KidneyMatchgrid
CategoryOrgan Matching Software
4BREEZE™ Preoperative
CategoryPreoperative Assessment Software
5BREEZE™ Clinical Trials
CategoryClinical Trial Technology
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

MedSleuth partners with APKD to offer KidneyMatchgrid in the U.S., providing sophisticated matching software that gives transplant centers enhanced access to internal, regional and national matches with dedicated concierge-level support throughout the kidney donation process. The partnership leverages MedSleuth's technology platform with APKD's donor protection programs including DonorProtect benefits, APKD Kidney Promise, and KidneyPledge offerings.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Deep 6 AI
TypeEmerging player
Description

AI-driven patient-trial matching platform using EHR data, comparable to BREEZE Clinical Trials for site selection and patient enrollment in pharma-sponsored studies.

TypeDirect peer
Description

Provides transplant-specific software for organ procurement organizations and transplant centers, directly competing with MedSleuth's BREEZE Transplant module in the same customer base.

TypeDirect peer
Description

Patient intake and pre-visit workflow platform used by hospitals and health systems, directly competing with MedSleuth's BREEZE Preoperative module for patient history collection and preoperative assessment.

TypeBroad incumbent
Description

Large enterprise cloud software provider for life sciences, including clinical trial management and patient engagement tools, competing broadly with MedSleuth's Clinical Trials/REMS module in the pharma and CRO market.

TypeBroad incumbent
Description

Global leader in clinical research services and technology, offering site selection, patient recruitment, and trial management platforms that overlap with BREEZE Clinical Trials.

TypeBroad incumbent
Description

Dassault Systèmes subsidiary providing clinical trial technology including electronic data capture and patient engagement, competing with BREEZE Clinical Trials in the pharma and biotech customer segment.

TypeEmerging player
Description

Clinical trial patient-matching platform that uses EHR data to identify eligible patients for trials, an emerging alternative to MedSleuth's BREEZE Clinical Trials in site selection and enrollment.

8Mendel
TypeEmerging player
Description

AI-powered clinical trial matching platform that structures medical records for patient-trial eligibility, emerging as a partial substitute for BREEZE Clinical Trials in pharma recruitment workflows.

TypeBroad incumbent
Description

Dominant EHR vendor whose platform MedSleuth integrates with; Epic could choose to build competing transplant and preoperative workflows in-house, threatening MedSleuth's integration-dependent position.

10Oracle Health
TypeBroad incumbent
Description

Oracle's healthcare division (formerly Cerner) is a major EHR vendor whose transplant and clinical workflow capabilities could compete with MedSleuth's modules at large hospital customers.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

MedSleuth

Healthcare Workflow Softwaremedsleuth.com

MedSleuth builds the BREEZE™ cloud platform, which collects patient medical histories and supports U.S. transplant centers, hospitals, surgical centers, and clinical trial sponsors with modules for transplant management, kidney paired donation matching (via APKD), clinical trial enrollment, and preoperative risk assessment.

What MedSleuth does

MedSleuth is a San Francisco-based healthcare technology company that develops the BREEZE™ platform, a clinically-validated, cloud-based web application that collects medical histories directly from patients using proprietary clinical algorithms and a medication-driven recall methodology. The platform is delivered as four integrated modules — BREEZE Transplant (full transplant continuum from referral through donor/recipient follow-up and UNOS/CMS compliance), KidneyMatchgrid (paired kidney donation matching via a partnership with the Alliance for Paired Kidney Donation, powered by a Nobel Prize-winning optimization algorithm), BREEZE Clinical Trials (remote screening, enrollment, adverse event monitoring, and FDA REMS compliance for pharma sponsors and trial sites), and BREEZE Preoperative (standardized perioperative risk assessment for hospitals and surgical centers).

The company serves a focused set of U.S. institutional customers — transplant centers, hospitals, surgical centers, and clinical trial sponsors — through a consultative enterprise sales motion with demo requests and quote-based pricing on annual subscriptions. The platform integrates with customer EHRs, is HIPAA-compliant, holds SOC 2 Type II certification, and has been validated by the U.S. Department of Defense and the National Institutes of Health. Despite operating with a micro team of 1–10 employees, MedSleuth has positioned the BREEZE platform across multiple high-value clinical workflows, with product and partnership expansion activity concentrated in 2025 and an apparent structural linkage to DaVita indicated by privacy notice domains hosted at davita.com.

MedSleuth firmographics

Firmographics
Name
MedSleuth
Legal name
MedSleuth, Inc.
Website
https://medsleuth.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
1–10 employees
Short description
MedSleuth builds the BREEZE™ cloud platform, which collects patient medical histories and supports U.S. transplant centers, hospitals, surgical centers, and clinical trial sponsors with modules for transplant management, kidney paired donation matching (via APKD), clinical trial enrollment, and preoperative risk assessment.
Ownership category
akta.pro rank

MedSleuth industry classification

Industry
Product category
Healthcare Workflow Software
NAICS
Computer Systems Design and Related Services (54151), Home Health Care Services (621610)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLACAFAL
Connected Therapeutics & Smart Drug Delivery Monitoring
Healthcare & Life Sciences/Digital Health & Health IT/Remote Patient Monitoring (RPM) & Connected Care Platforms
SECONDARYHLACAPAH
Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring

Keywords

  • Healthcare workflow software
  • Transplant management software
  • Preoperative assessment platform
  • Clinical trial patient screening
  • Medical history automation

Where MedSleuth is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Markets served

MedSleuth business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. BREEZE™ Software Licensing: Enterprise software licensing model for BREEZE™ platform deployed to healthcare providers including transplant centers, hospitals, and clinical trial sites. The platform appears to be sold as a subscription-based or per-transaction model targeting institutional healthcare customers.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise licensing with custom pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

MedSleuth product offering

Product offering

Core offering

MedSleuth develops and sells the BREEZE™ web-based platform, a clinically-validated software suite that automates medical history collection, patient eligibility screening, and clinical workflow management for transplant centers, hospitals, surgical centers, and clinical trial sponsors. The suite includes specialized modules for transplant management (BREEZE Transplant™), kidney donor-recipient matching (KidneyMatchgrid), preoperative assessment (BREEZE™ Preoperative), and clinical trial patient onboarding (BREEZE™ Clinical Trials).

Product overview

MedSleuth is a unified healthcare technology platform built around its core BREEZE™ software product. The platform consists of multiple integrated modules: BREEZE Transplant™ for managing the full kidney transplant continuum from referral through follow-up; KidneyMatchgrid, a kidney matching tool developed in partnership with APKD that uses a Nobel Prize-winning algorithm for paired donation optimization; BREEZE™ Clinical Trials for patient enrollment and REMS compliance; and BREEZE™ Preoperative for standardized preoperative risk assessment. All modules share the same web-based platform architecture for collecting medical histories directly from patients.

Differentiator

Problem solved

Functional benefit

Brands

  • BREEZE: A clinically-validated web-based platform for collecting medical histories directly from patients, used for transplant management, preoperative assessments, and clinical trials. Includes modules for recipient referral, candidate evaluation, waitlist management, living donor evaluation, and follow-up.
  • KidneyMatchgrid

Products and services

  • BREEZE™ Clinical Platform
  • BREEZE Transplant™
  • KidneyMatchgrid
  • BREEZE™ Preoperative
  • BREEZE™ Clinical Trials

Quantifiable outcome

  • 97% Ease of Use rating from users
  • +5 more outcomes

Companies that use MedSleuth

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

MedSleuth technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

MedSleuth partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Alliance for Paired Kidney Donation (APKD)coreStrategic or Co-development PartnerMedSleuth partners with APKD to offer KidneyMatchgrid in the U.S., providing sophisticated matching software that gives transplant centers enhanced access to internal, regional and national matches with dedicated concierge-level support throughout the kidney donation process. The partnership leverages MedSleuth's technology platform with APKD's donor protection programs including DonorProtect benefits, APKD Kidney Promise, and KidneyPledge offerings.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

MedSleuth competitors and assessment

Company assessment

Emerging players

  • Deep 6 AI: AI-driven patient-trial matching platform using EHR data, comparable to BREEZE Clinical Trials for site selection and patient enrollment in pharma-sponsored studies.
  • TriNetX: Clinical trial patient-matching platform that uses EHR data to identify eligible patients for trials, an emerging alternative to MedSleuth's BREEZE Clinical Trials in site selection and enrollment.
  • Mendel: AI-powered clinical trial matching platform that structures medical records for patient-trial eligibility, emerging as a partial substitute for BREEZE Clinical Trials in pharma recruitment workflows.

Direct peers

  • Transplant Connect: Provides transplant-specific software for organ procurement organizations and transplant centers, directly competing with MedSleuth's BREEZE Transplant module in the same customer base.
  • Phreesia: Patient intake and pre-visit workflow platform used by hospitals and health systems, directly competing with MedSleuth's BREEZE Preoperative module for patient history collection and preoperative assessment.

Broad incumbents

  • Veeva Systems: Large enterprise cloud software provider for life sciences, including clinical trial management and patient engagement tools, competing broadly with MedSleuth's Clinical Trials/REMS module in the pharma and CRO market.
  • IQVIA: Global leader in clinical research services and technology, offering site selection, patient recruitment, and trial management platforms that overlap with BREEZE Clinical Trials.
  • Medidata Solutions: Dassault Systèmes subsidiary providing clinical trial technology including electronic data capture and patient engagement, competing with BREEZE Clinical Trials in the pharma and biotech customer segment.
  • Epic Systems: Dominant EHR vendor whose platform MedSleuth integrates with; Epic could choose to build competing transplant and preoperative workflows in-house, threatening MedSleuth's integration-dependent position.
  • Oracle Health: Oracle's healthcare division (formerly Cerner) is a major EHR vendor whose transplant and clinical workflow capabilities could compete with MedSleuth's modules at large hospital customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

MedSleuth compliance and trust

Trust signal

Compliance2 records

MedSleuth financial estimates

Financial estimate

Revenue estimate

Valuation estimate

MedSleuth leadership team

Management profile

Number of profiles

MedSleuth funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

MedSleuth M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MedSleuth

What does MedSleuth do?

MedSleuth develops and sells the BREEZE™ web-based platform, a clinically-validated software suite that automates medical history collection, patient eligibility screening, and clinical workflow management for transplant centers, hospitals, surgical centers, and clinical trial sponsors. The suite includes specialized modules for transplant management (BREEZE Transplant™), kidney donor-recipient matching (KidneyMatchgrid), preoperative assessment (BREEZE™ Preoperative), and clinical trial patient onboarding (BREEZE™ Clinical Trials).

Is MedSleuth a public or private company?

MedSleuth is a private company. It is classified as unknown and is currently operating.

When was MedSleuth founded?

MedSleuth was founded in 2015. It employs 1 to 10 people.

Where is MedSleuth based?

MedSleuth is headquartered in San Francisco, United States, in the North America region.

How does MedSleuth make money?

One revenue line is on record: BREEZE™ Software Licensing.

Who are MedSleuth's main competitors?

Emerging players on record are Deep 6 AI, TriNetX and Mendel. Direct peers are Transplant Connect and Phreesia. Broad incumbents are Veeva Systems, IQVIA, Medidata Solutions, Epic Systems and Oracle Health.

Does MedSleuth have an API?

No public API is recorded for MedSleuth.

What industry is MedSleuth in?

MedSleuth's product category is Healthcare Workflow Software. Its primary akta.pro industry code is HLACAFAL, Connected Therapeutics & Smart Drug Delivery Monitoring, with a secondary code of HLACAPAH, Medication Adherence & Smart Drug Delivery (Connected Inhalers, Pens, Pill Dispensers). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals